Didar Yanardag Acik (Didar Yanardağ Açık)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Lipopolysaccharide Induced

Acute Myeloid Leukemia

Angiotensin Converting Enzyme

Hodgkin Lymphoma

Top Venues

Scandinavian journal of clinical and laboratory investigation

Clinical case reports

Journal of chemotherapy (Florence, Italy)

Adana Numune Egitim ve Arastirma Hastanesi

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Adana Numune Egitim ve Arastirma Hastanesi

Turkey

Specialist :: Hematology

Publications

Bahar Uncu Ulu, Mehmet Sinan Dal, İpek Yönal Hindilerden, Olga Meltem Akay Yanar, Özgür Mehta, Nurhilal Büyükkurt, Fehmi Hindilerden, Ahmet Kursad Gunes, Tuğçe Nur Yiğenoğlu, Başcı Semih, Merih Kızıl Çakar, Didar Yanardag Acik, Serdal Korkmaz, Turgay Ulas, Gülsüm Özet, Burhan Ferhanoğlu, Meliha Nalçacı, Fevzi Altuntaş
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients. Journal of chemotherapy (Florence, Italy) (2021)
Guzin Ozden, Didar Yanardag Acik
Can the neutrophil-lymphocyte ratio predict type 1 hereditary angioedema attacks? Scandinavian journal of clinical and laboratory investigation 80 (8) (2020)
Didar Yanardag Acik, Mehmet Bankir, Filiz Alkan Baylan, Bilal Aygun
Can ELABELA be a novel target in the treatment of chronic lymphocytic leukaemia? BMC cancer 19 (1) (2019)
Didar Yanardag Acik
Recognizing the unusual findings: Cases of desiderosmia. Clinical case reports 7 (5) (2019)